Seluna secures £650K in funding to enhance diagnostics for childhood sleep disorders and launches a major clinical trial.

Aug 28, 2025•4 months ago

Amount Raised

£650,000

GlasgowArtificial IntelligenceBiotechnologyHealth Care

Investors

Stac InvestUniversity Of StrathclydeScottish EnterpriseGabriel Investment Syndicate

Description

Seluna has raised nearly £650,000 to support a clinical validation study aimed at improving the diagnosis of childhood sleep disorders. The company is focused on developing a software as a medical device that streamlines the diagnostic pathway. Existing backers include Gabriel Investment Syndicate, Scottish Enterprise, and the University of Strathclyde, along with new investor STAC Invest. The study will validate Seluna's innovative software through research involving 500 patients under 18.

Company Information

Company

Seluna

Location

Glasgow, Scotland, United Kingdom

About

Seluna is a Glasgow-based medtech company focused on improving the diagnosis and management of childhood sleep disorders. They aim to develop the first software as a medical device (SaMD) specifically for diagnostics in paediatric sleep medicine. The company utilizes machine learning to automate the interpretation of sleep study data, enhancing clinical decision-making and reducing workload. Their current clinical validation study involves 500 patients and aims to demonstrate the effectiveness of their diagnostic software.

Related People

2 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends